Genotyping

About:

Genotyping brings precision medicine to consumers through genetic diagnosis using next-generation sequencing technology.

Website: http://genotyping.com.br/

Twitter/X: genotyping_sp

Top Investors: SP Ventures

Description:

Genotyping brings precision medicine to consumers through genetic diagnosis using next-generation sequencing technology. Genotyping is a Brazilian biotechnology company founded in 2008 by UNESP researchers together with entrepreneurs. In 2013, the company expanded its operations to the molecular diagnostics industry, pioneering the next-generation sequencing to use for genetic analysis. Located in Botucatu, it has a modern laboratory with operating license that is FDA approved, has qualified and personalized customer service. The company has scientific and technical body able to perform a full range of molecular analysis of the human genome, enabling the development of new tests to meet specific customer needs. The company provides genetic panels that assess multiple genes in a single analysis, enabling physicians to offer patients the latest diagnosis associated with prevention.

Total Funding Amount:

4M BRL

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Botucatu, Sao Paulo, Brazil

Founded Date:

2008-01-01

Contact Email:

contato(AT)genotyping.com.br

Founders:

Number of Employees:

1-10

Last Funding Date:

2015-09-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai